Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Victoria M. Gammino"'
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 14, Iss 7, p e0008474 (2020)
The estimated 50 million nomadic pastoralists in Africa are among the most "hard-to-reach" populations for health-service delivery. While data are limited, some studies have identified these communities as potential disease reservoirs relevant to neg
Externí odkaz:
https://doaj.org/article/a8d84cdb1c5e426c995cada8d715a299
Autor:
Molly R. Kurnit, Victoria M. Gammino, Michael R. Diaz, Abigail R Greenleaf, Sarah Wood Pallas
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 14, Iss 7, p e0008474 (2020)
PLoS Neglected Tropical Diseases
PLoS Neglected Tropical Diseases
The estimated 50 million nomadic pastoralists in Africa are among the most “hard-to-reach” populations for health-service delivery. While data are limited, some studies have identified these communities as potential disease reservoirs relevant to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::daddd06cae1585fd23ae2214ceb84348
https://doi.org/10.1371/journal.pntd.0008474
https://doi.org/10.1371/journal.pntd.0008474
Autor:
Victoria M. Gammino, Sue Gerber, David E. Sugerman, Molly R. Kurnit, Alex Gasasira, Fadinding Manneh, Paul Chenoweth, Adamu Nuhu, Emmanuel Abanida
Publikováno v:
Journal of Infectious Diseases. 210:S91-S97
BACKGROUND As 1 of 3 remaining poliovirus-endemic countries, Nigeria has become key to the global polio eradication effort. We evaluated supplemental immunization activities, including team performance, communications/mobilization activities, and vac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4d80082dcfe8736b49190a1223b56cb
https://doi.org/10.1093/infdis/jiu228
https://doi.org/10.1093/infdis/jiu228
Autor:
Joconiah Chirenda, Heather J. Menzies, R. Makombe, James Shepherd, O. Kachuwaire, Kevin P. Cain, T. Maribe, B. Kim, K. Radisowa, C. Sentle, V. Anisimova, S. El-Halabi, Marcus A. Bachhuber, E. Bile, Taraz Samandari, G. Moalosi, Victoria M. Gammino, J. Basotli
Publikováno v:
The International Journal of Tuberculosis and Lung Disease. 18:1026-1033
Setting Although approximately 0.5 million cases of multidrug-resistant tuberculosis (MDR-TB) occur globally each year, surveillance data are limited. Botswana is one of the few high TB burden countries to have carried out multiple anti-tuberculosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bac3245b45d801cd7aa1cb80f32f466a
https://doi.org/10.5588/ijtld.13.0749
https://doi.org/10.5588/ijtld.13.0749
Autor:
Irina Gelmanova, Allison Taylor, Ekaterina V. Kurbatova, J P Cegielski, Vija Riekstina, Matteo Zignol, Manfred Danilovitz, M. I. D. Quelapio, Vaira Leimane, Salmaan Keshavjee, Carole D. Mitnick, Mercedes C. Becerra, Victoria M. Gammino, Dennis Falzon, Piret Viiklepp, Jaime Bayona
Publikováno v:
The International Journal of Tuberculosis and Lung Disease. 16:1335-1343
Objective To identify predictors of initial sputum culture conversion, estimate the usefulness of persistent positive cultures at different time points in predicting treatment failure, and evaluate different definitions of culture conversion for pred
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df02bc27da733f25e908d4a73dc6c49d
https://doi.org/10.5588/ijtld.11.0811
https://doi.org/10.5588/ijtld.11.0811
Autor:
Vija Riekstina, Irina Gelmanova, Carole D. Mitnick, Vaira Leimane, Dennis Falzon, Matteo Zignol, Mercedes C. Becerra, Piret Viiklepp, Victoria M. Gammino, Allison Taylor, Ma. Imelda Quelapio, J. Peter Cegielski, Manfred Danilovitz, Salmaan Keshavjee, Ekaterina V. Kurbatova, Jaime Bayona
Publikováno v:
Tuberculosis. 92:397-403
The Objective of this analysis was to identify predictors of death, failure, and default among MDR-TB patients treated with second-line drugs in DOTS-plus projects in Estonia, Latvia, Philippines, Russia, and Peru, 2000-2004. Risk ratios (RR) with 95
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bae0512802ee18731d80a9c9e1a784e
https://doi.org/10.1016/j.tube.2012.06.003
https://doi.org/10.1016/j.tube.2012.06.003
Autor:
Vija Riekstina, Ekaterina V. Kurbatova, M. I. D. Quelapio, Matteo Zignol, Salmaan Keshavjee, Piret Viiklepp, Allison Taylor, J P Cegielski, Irina Gelmanova, Carole D. Mitnick, Jaime Bayona, Mercedes C. Becerra, Dennis Falzon, Victoria M. Gammino, Vaira Leimane, Manfred Danilovitz
Publikováno v:
The International Journal of Tuberculosis and Lung Disease. 15:1553-1556
Monthly culture is usually recommended to monitor treatment of multidrug-resistant tuberculosis (MDR-TB). As mycobacterial laboratory capacity is limited in many settings, TB programs need evidence to decide whether monthly cultures are necessary com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ece246a77ae5670561a907795b910b93
https://doi.org/10.5588/ijtld.11.0101
https://doi.org/10.5588/ijtld.11.0101
Autor:
Mercedes C. Becerra, Victoria M. Gammino, Cesar Bonilla, M. I. D. Quelapio, Vaira Leimane, Matteo Zignol, Michael Rich, Peter Cegielski, Salmaan Keshavjee, V. Riektsina, Ernesto Jaramillo, Irina Gelmanova, Carole D. Mitnick, Jaime Bayona, Charles D. Wells, Allison Taylor, Thelma E. Tupasi, V. Hollo
Publikováno v:
The International Journal of Tuberculosis and Lung Disease. 15:1315-1322
BACKGROUND Multidrug-resistant tuberculosis programs in DOTS-Plus pilot sites in five countries. OBJECTIVES To calculate sputum conversion time and its relationship to treatment outcome, document the frequency of culture reversions and examine concor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ac83c9f39279f54cb31934e869e73798
https://doi.org/10.5588/ijtld.10.0221
https://doi.org/10.5588/ijtld.10.0221
Publikováno v:
Current Infectious Disease Reports. 12:36-45
Drug-resistant tuberculosis (DRTB) is an emerging infectious disease threat to sub-Saharan Africa (SSA), particularly in the regions hit hardest by the HIV epidemic. Numerous challenges face clinicians and public health officials tasked with combatin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af2554cb51850452d1338a2f38c60a49
https://doi.org/10.1007/s11908-009-0074-7
https://doi.org/10.1007/s11908-009-0074-7
Autor:
Hee Jin Kim, Laura E. Via, Boris Y. Kazennyy, Salmaan Keshavjee, Imelda D. Quelapio, Rattanawadee Akksilp, Matteo Zignol, Martie van der Walt, Vija Riekstina, Martin Yagui, Olga V. Demikhova, Christian Lienhardt, Grigory V. Volchenkov, Tracy Dalton, Allison Taylor Walker, Janice Campos Caoili, Kai Kliiman, Ekaterina V. Kurbatova, Mercedes C. Becerra, Thelma E. Tupasi, Carmen Contreras, J. Peter Cegielski, Sarah Smith, Victoria M. Gammino, Julia Ershova, Charles M. Heilig, Charlotte Kvasnovsky, Jaime Bayona, Vaira Leimane, Irina Gelmanova, Melanie Wolfgang, Carole D. Mitnick, Irina Vasilyeva, Ruwen Jou, Manfred Danilovits, Piret Viiklepp
Publikováno v:
The Lancet. Respiratory medicine. 3(3)
Sputum culture conversion is often used as an early microbiological endpoint in phase 2 clinical trials of tuberculosis treatment on the basis of its assumed predictive value for end-of-treatment outcome, particularly in patients with drug-susceptibl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c32081132758042f2fa27c0d6cd48ef8
https://pubmed.ncbi.nlm.nih.gov/25726087
https://pubmed.ncbi.nlm.nih.gov/25726087